Zobrazeno 1 - 10
of 235
pro vyhledávání: '"Joost. L. Boormans"'
Autor:
Florus C. de Jong, Iris G. Iflé, Angelique C. van der Made, Denise Kooper, Joep J. de Jong, Martine Franckena, Tahlita C.M. Zuiverloon, Wim van Criekinge, Luca Incrocci, Ellen C. Zwarthoff, Joost L. Boormans
Publikováno v:
European Urology Open Science, Vol 62, Iss , Pp 131-139 (2024)
Background: Patients with muscle-invasive bladder cancer (MIBC) who receive radiotherapy with curative intent are followed by imaging, cystoscopy, and urine cytology. However, interpretation of cytology and cystoscopy is hampered by the impact of ion
Externí odkaz:
https://doaj.org/article/08888ae2e23b41d0be2126ee9793bc6a
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 9- (2024)
Externí odkaz:
https://doaj.org/article/fbd9f22792254e879e34a1e55491eeef
Autor:
Maud Rijnders, J. Alberto Nakauma-González, Debbie G. J. Robbrecht, Alberto Gil-Jimenez, Hayri E. Balcioglu, Astrid A. M. Oostvogels, Maureen J. B. Aarts, Joost L. Boormans, Paul Hamberg, Michiel S. van der Heijden, Bernadett E. Szabados, Geert J. L. H. van Leenders, Niven Mehra, Jens Voortman, Hans M. Westgeest, Ronald de Wit, Astrid A. M. van der Veldt, Reno Debets, Martijn P. Lolkema
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Immune checkpoint inhibitors (ICI) improve overall survival in patients with metastatic urothelial cancer (mUC), but therapeutic success at the individual patient level varies significantly. Here we identify predictive markers of response, b
Externí odkaz:
https://doaj.org/article/5c826962a5fb45ffbb47fc08f0218098
Autor:
Thomas van Doeveren, Sebastiaan Remmers, Vera Atema, Roderick C.N. van den Bergh, Egbert R. Boevé, Erik B. Cornel, Antoine G. van der Heijden, Kees Hendricksen, Evelyne C.C. Cauberg, Rens A.L. Jacobs, Bin K. Kroon, Annemarie M. Leliveld, Richard P. Meijer, Bob Merks, Jorg R. Oddens, Luc Roelofs, Diederik M. Somford, Peter de Vries, Bart Wijsman, Willemijn A.K.M. Windt, Peter J. Zwaan, Pim J. van Leeuwen, Joost L. Boormans, Katja K.H. Aben
Publikováno v:
European Urology Open Science, Vol 60, Iss , Pp 15-23 (2024)
Background and objective: The possible negative impact of radical surgery on patients’ health-related quality of life (HRQoL) plays an important role in preoperative counseling. Here, we analyzed the HRQoL of patients treated for upper urinary trac
Externí odkaz:
https://doaj.org/article/c8009cb80c0b4b348bd25c12161f4e5a
Autor:
Miriam Angeloni, Thomas vanDoeveren, Sebastian Lindner, Patrick Volland, Jorina Schmelmer, Sebastian Foersch, Christian Matek, Robert Stoehr, Carol I Geppert, Hendrik Heers, Sven Wach, Helge Taubert, Danijel Sikic, Bernd Wullich, Geert JLH vanLeenders, Vasily Zaburdaev, Markus Eckstein, Arndt Hartmann, Joost L Boormans, Fulvia Ferrazzi, Veronika Bahlinger
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 2, Pp n/a-n/a (2024)
Abstract Upper tract urothelial carcinoma (UTUC) is a rare and aggressive, yet understudied, urothelial carcinoma (UC). The more frequent UC of the bladder comprises several molecular subtypes, associated with different targeted therapies and overlap
Externí odkaz:
https://doaj.org/article/ea49233d91ae4f1c9eec6b27ab16c36c
Autor:
Ben-Max de Ruiter, Maaike W. van de Kamp, Jonah P.Z. van Steenbergen, Martine Franckena, Joost L. Boormans, Jeantine M. de Feijter, Adriaan D. Bins, Maarten C.C.M. Hulshof, Theo M. de Reijke, Eva Schaake, Jorg R. Oddens
Publikováno v:
European Urology Open Science, Vol 39, Iss , Pp 7-13 (2022)
Background: Concurrent chemoradiotherapy (CRT) as a definitive treatment option for patients with nonmetastatic muscle-invasive bladder carcinoma (MIBC) is increasingly being applied in clinical practice. Objective: To assess the oncological and toxi
Externí odkaz:
https://doaj.org/article/e0a549a6bfef4220b4eb6863be5da434
Autor:
J Alfred Witjes, Alina Vrieling, Mihai G Netea, Leo A B Joosten, Katja K H Aben, Sita H Vermeulen, Joost L Boormans, Antoine G van der Heijden, Boris Novakovic, Jelmer H van Puffelen, Liesbeth van Emst, Denise Kooper, Tahlita C M Zuiverloon, Ursula T H Oldenhof, Tessel E Galesloot, Lambertus A L M Kiemeney, Egbert Oosterwijk
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background BCG is recommended as intravesical immunotherapy to reduce the risk of tumor recurrence in patients with non-muscle invasive bladder cancer (NMIBC). Currently, it is unknown whether intravesical BCG application induces trained immunity.Met
Externí odkaz:
https://doaj.org/article/f160d417e5fc4088a9372dbbdff54fa8
Autor:
Joep J. de Jong, Yang Liu, A. Gordon Robertson, Roland Seiler, Clarice S. Groeneveld, Michiel S. van der Heijden, Jonathan L. Wright, James Douglas, Marc Dall’Era, Simon J. Crabb, Bas W. G. van Rhijn, Kim E. M. van Kessel, Elai Davicioni, Mauro A. A. Castro, Yair Lotan, Ellen C. Zwarthoff, Peter C. Black, Joost L. Boormans, Ewan A. Gibb
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-13 (2019)
Abstract Background Muscle-invasive bladder cancer (MIBC) is a heterogeneous disease, and gene expression profiling has identified several molecular subtypes with distinct biological and clinicopathological characteristics. While MIBC subtyping has p
Externí odkaz:
https://doaj.org/article/f48f6e80fa2e412ea8f4dae7124976e4
Autor:
Lambertus A Kiemeney, Anke Richters, Richard P Meijer, Niven Mehra, Joost L Boormans, Antoine G van der Heijden, Michiel S van der Heijden, Katja K Aben
Publikováno v:
BMJ Open, Vol 11, Iss 5 (2021)
Introduction A better understanding of the molecular profile of bladder tumours, the identification of novel therapeutic targets, and introduction of new drugs and has renewed research interest in the field of bladder cancer. We describe the design a
Externí odkaz:
https://doaj.org/article/ac0d678092ef478f95460604e0eff0c5
Autor:
Maximilian Pallauf, David D’Andrea, Frederik König, Ekaterina Laukhtina, Takafumi Yanagisawa, Morgan Rouprêt, Siamak Daneshmand, Hooman Djaladat, Alireza Ghoreifi, Francesco Soria, Kazutoshi Fujita, Stephen A. Boorjian, Aaron M. Potretzke, Andrea Mari, Mathieu Roumiguié, Alessandro Antonelli, Alberto Bianchi, Zine-Eddine Khene, John P. Sfakianos, Marcus Jamil, Joost L. Boormans, Jay D. Raman, Nico C. Grossmann, Alberto Breda, Axel Heidenreich, Francesco Del Giudice, Nirmish Singla, Shahrokh F. Shariat, Benjamin Pradere
Publikováno v:
Journal of Urology, 209(3), 515-524. Elsevier Inc.
Purpose:Treatment options for the management of upper tract urothelial cancer are based on accurate staging. However, the performance of conventional cross-sectional imaging for clinical lymph node staging (N-staging) remains poorly investigated. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f908926d979b9d33d29e3c5de86c79
http://www.scopus.com/inward/record.url?scp=85147783364&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85147783364&partnerID=8YFLogxK